Empyrean Capital Partners’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Empyrean Capital Partners’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-24,000	Closed	-$1.28M	–	110
2016 Q1	$1.28M	Buy	+24,000	New	+$1.77M	0.05%	78

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Empyrean Capital Partners's ANAC Position: Q2 2016 in Review

Empyrean Capital Partners sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 24,000 shares — an estimated $1.28M sold.

Empyrean Capital Partners first reported a position in ANAC in Q1 2016 and held it in 1 quarter. The position peaked at $1.28M in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Empyrean Capital Partners reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Empyrean Capital Partners sold 24,000 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $1.28M.
Empyrean Capital Partners first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2016 and held it in 1 quarter.
Empyrean Capital Partners's ANACOR PHARMACEUTICALS INC COM position peaked at $1.28M in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Empyrean Capital Partners's 13F filing for Q2 2016, filed 15 Aug 2016.